Sepsis and endotoxemia induce a state of early tolerance to the biological effects of endotoxin. Relatively little is known about the mechanisms or mediators involved in this endotoxin hyporesponsiveness. In this study endotoxin-induced TNF production of whole blood obtained at different time points from endotoxin challenged volunteers, and endotoxin- and PHA-induced TNF production by healthy PBMNCs in the presence of serum from endotoxin challenged volunteers were compared.
Endotoxin-induced TNF production by whole blood was found to be significantly reduced at 2 h after in vivo endotoxin administration, returning to baseline levels at t = 6 h. In addition, a reduction of TNF produced by healthy PBMNCs in the presence of post-endotoxin serum was observed. No correlation was found with the concentration of any of the well described anti-inflammatory mediators investigated nor with plasma levels of endotoxin-binding proteins.
Get full access to this article
View all access options for this article.
References
1.
Greisman S.E. , Young E.J., Carozza Jr F.A. Mechanisms of endotoxin tolerance. V. Specificity of the early and late phases of pyrogenic tolerance . J Immunol1969; 103: 1223-1236.
2.
Greisman S.E. , Hornick R.B., Carozza Jr F.A., Woodward T.E. The role of endotoxin during typhoid fever and tularemia in man. I. Acquisition of tolerance to endotoxin. J Clin Invest1963 ; 42: 1064-1075.
3.
Greisman S.E. , Woodward T.E.Mechanisms of endotoxin tolerance. III. The refractory state during continuous intravenous infusions of endotoxin . J Exp Med1965; 121: 911-933.
4.
Greisman S.E. , Hornick R.B.Mechanisms of endotoxin tolerance with special reference to man. J Infect Dis1973; 128 (Suppl.): 265-276
5.
Munoz C., Carlet J., Fitting C., Misset B., Biérot J.P., Cavaillon J.M.Dysregulation on in vitro cytokine production by monocytes during sepsis. J Clin Invest1991; 88: 1747-1754.
6.
Helminen M.Interleukin-1 production from peripheral blood monocytes in septic infections in children. Scand J Infect Dis1991;23:607-611.
7.
Simpson S.Q. , Modi H.N., Balk R.A., Bone R.C., Casey L.C.Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men . Crit Care Med1991; 19: 1060-1066.
8.
Ayala A., Kisala J.M., Felt J.A., Perrin M.M., Chaudry I.H.Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis?Arch Surg1992; 127: 191-197.
9.
Johnston C.A. , Greisman S.E.Mechanisms of endotoxin tolerance. Chapter 14. In: Hinshaw L.B. ed Handbook of Endotoxin, vol. 2, Pathophysiology of Endotoxin. Amsterdam: Elsevier, 1985; 359-399.
10.
Rodrick M.L. , Wood JJ, O'Mahony J.B. et al. Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: production of interleukin 1 and 2. J Clin Immunol1986; 6: 310-318.
11.
Greisman S.E. , Young E.J., DuBuy B.Mechanism of endotoxin tolerance. VIII. Specificity of serum transfer. J Immunol1973; 3: 1349-1360.
12.
Larsen N.E. , Sullivan R.Interaction between endotoxin and human monocytes: characteristics of the binding of 3H-labeled lipopolysaccharide and 51Cr-labeled lipid A before and after the induction of endotoxin tolerance . Proc Natl Acad Sci USA1984; 81: 3491-3495.
13.
Fahmi H., Chaby R.Desensitization of macrophages to endotoxin effects is not correlated with a downregulation of lipopolysaccharide-binding sites. Cell Immunol1993; 150: 219-229.
14.
McCall C.E. , Grosso-Wilmoth L.M., LaRue K., Guzman R.N., Cousart S.L.Tolerance to endotoxin-induced expression of the interleukin-1β gene in blood neutrophils of humans with the sepsis syndrome. J Clin Invest1993; 91: 853-861.
Zingarelli B., Makhlouf M., Halushka P.V., Caputi A.P., Cook J.A.Altered macrophage function in tumor necrosis factor-α and endotoxin-tolerance. J Endotoxin Res1995; 2: 247-254.
17.
Dentener M.A. , Francot G.J.M., Smit F.T. et al. Presence of bactericidal/permeability increasing protein in disease; detection by ELISA . J Infect Dis1995; 171: 739-743.
18.
White M.L., Ma J.K., Birr C.A., Trown P.W., Carroll S.F.Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA. J Immunol Methods1994;167:227-237
19.
van de Poll T., Jansen J., van Leenen D. et al. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis1993; 168: 955-960.
20.
van de Poll T. , Jansen J., Levi M., ten Cate H., ten Cate J.W., van Deventer S.J.H.Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees . J Exp Med1994; 180: 1985-1988.
21.
Engelberts I. , Moller A., Schoen G.J.M., van der Linden C.J., Buurman W.A.Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Res1991; 10: 69-76.
22.
Bruin K.F., von der Möhlen M.A.M., Jansen J., Prins M.H., ten Cate J.W., van Deventer S.J.H.Septic serum inhibits endotoxin-induced tumor necrosis factor release by human peripheral blood mononuclear cells. In: Thesis: Endotoxin Responsiveness in Humans. Amsterdam: Thesis Publishers , 1994; 78-92.
23.
von der Möhlen M.A.M., Kimmings A.N., Wedel N.I. et al. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans using recombinant bactericidal/permeability-increasing protein (rBPI23). J Infect Dis1995; 172: 144-151.
24.
Rodrick M.L. , Moss N.M., Grbic J.T. et al. Effects of in vivo endotoxin infusions on in vitro cellular immune responses in humans. J Clin Immunol1992, 12: 440-450.
25.
Olofsson P. , Olofsson C., Nylander G., Olsson P.Endotoxin inactivation in plasma from septic patients: an in vitro study. World J Surg1986; 10: 318-323.
26.
Ulevitch R.J. , Johnston A.R.The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J Clin Invest1978; 62: 1313-1324.
27.
Granowitz E.V. , Porat R., Mier J.W. et al. Intravenous endotoxin suppresses the cytokine response of periferal blood mononuclear cells of healthy humans . J Immunol1993; 151: 1637-1645.
28.
Haas J.G., Thiel C., Blomer K., Weiss E.H., Riethmüller G., Ziegler-Heitbrock H.W.L.Downregulation of tumor necrosis factor expression in the human Mono-Mac-6 cell line by lipopolysaccharide. J Leukocyte Biol1989; 46: 11-14.
29.
Ziegler-Heitbrock H.W., Blumenstein M., Kafferlein E. et al. In vitro desensitization to lipopolysaccharide suppresses tumor necrosis factor, interleukin-1 and interleukin-6 gene expression in a similar fashion. Immunology1992; 75: 264-268.
Takasuka N. , Tokunaga T., Akagawa K.S.Preexposure of macrophages to low doses of lipopolysaccharide inhibits the expression of tumor necrosis factor-α mRNA but not of IL-1β mRNA. J Immunol1991; 146: 3824-3830.
32.
Granowitz E.V. , Santos A.A., Poutsiaka D.D. et al. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet1991; 338: 1423-1424.
33.
Henricson B.E. , Neta R., Vogel S.N.An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun1991 ; 59: 1188-1191.
34.
de Waal-Malefyt R., Abrams R.J., Bennett B., Figdor C.G., de Vries J.Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes . J Exp Med1991 ; 174; 1209-1220.
35.
Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A.IL-10 inhibits cytokine production by activated macrophages. J Immunol1991; 147: 3815-3822.
36.
Gerard C., Bruyns C., Marchant A. et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med1993; 177: 547-550.
37.
Berg D.J., Kühn R., Rajewski K. et al. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest1995; 96: 2339-2347.
38.
Marra M.N., Wilde C.G., Collins M.S., Snable J.L., Thornton M.B., Scott R.W.The role of bactericidal/permeability increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol1992; 148: 532-537.
